Skip to Main Content

Paper Details

Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy.
iScience
5
2021
APC, ERCC3, FANCL, GVITMB, Germline, MSH6, PMS2, SLC25A13, TMB, TP53, cancer, cancers, cutaneous melanoma, gene sets, germline variants, patients, tumor, tumors
Author NameAffiliation
Ajay ChatrathUniversity of Virginia
Aakrosh RatanCenter for Public Health Genomics, University of Virginia
Anindya DuttaUniversity of Virginia
  • 1 - 3

Datasets

Release 1.2